vericiguat
Drug Details
- Generic Name
- vericiguat
- Brand Names
- VERQUVO
- Application Number
- NDA214377
- Sponsor
- Bayer AG
- NDC Codes
- 6
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- VERICIGUAT
Indications and Usage
1 INDICATIONS AND USAGE VERQUVO ® is indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45% [see Clinical Studies (14) ] . VERQUVO is a soluble guanylate cyclase (sGC) stimulator, indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less than 45%. ( 1 )